Why is Genfit stock gaining today?
Why is Genfit stock gaining today?
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
Why is Genfit stock gaining today?
GTCO declares N1.00 interim dividend per share
Spain September preliminary CPI +4.9% vs +4.6% y/y expected Prior +4.3% Spain September preliminary HICP +5.0% vs +4.9% y/y expected Prior +4.6% The breakdownThe numbers are running hotter than expected with headline annual inflation climbing to 4.9%, its highest since February 2023. Meanwhile, core annual inflation is also seen accelerating further from 2.9% to 3.1% in September. That suggests…
Cytokinetics CEO Robert Blum sells $490,949 in stock
Roth/MKM initiates Nautilus Biotechnology stock with buy rating
Roth/MKM initiates Rapid Micro Biosystems stock with buy rating
Japan stocks lower at close of trade; Nikkei 225 down 0.47%
Stadler Rail names Philipp Brunner CEO from 2027, targets profit growth
Thalia Therapeutics receives China patent for AML drug miRisten
Stifel upgrades STAAR Surgical stock rating on China growth outlook
EUROPEAN SESSION In the European session, the main highlight is the Spanish CPI report. Headline CPI Y/Y is expected to rise further to 4.6% vs 4.3% prior, but the focus will be on the Core measure which has ticked lower to 2.9% in the prior reading. The market is currently pricing roughly a 31% chance of an ECB rate hike in October, so if we get hot inflation numbers this week, we should see…
Akamai EVP Mani Sundaram sells $882k in company stock
Australia stocks higher at close of trade; S&P/ASX 200 up 0.34%
A.G. Barr keeps 2026 outlook as first-half revenue rises 8.5%
Meridian Mining to join FTSE 250 index on October 1
Goldstone Resources secures gold loan interest waiver extension
The swap service identified more than $50 million in attempted transfers, although most rejected funds subsequently moved through other providers.
Tap Global buys 3 bitcoin for balance sheet reserve strategy
Pepco raises FY26 earnings outlook, announces new €400 million buyback
Abingdon Health’s lab receives ISO/IEC 17025 accreditation
News text belongs to its source; only the headline and a short summary appear here.